Finland to prioritise FP7 agreement and boosting innovation during Presidency

EU PresidencyFinland has announced its priorities for research and innovation during its Presidency of the EU, started on 1 July: concluding negotiations on the Seventh Framework Programme (FP7); and developing a broad-based innovation policy.

The Presidency will kick-off its six months at the helm of the EU with an informal Competitiveness Council on 10 and 11 July in Jyväskylä, where it will present a background paper on innovation.

"I believe that innovation policy is very much the joint responsibility of all ministers responsible for the various strands of the Competitiveness Council and, during the meeting, would like to hear your views on the topic. It is my intention to take this theme forward together with the Commission during the autumn," writes Mauri Pekkarinen, Finland's Minister for Trade and Industry, in his letter of invitation.

The innovation policy that Finland wishes to promote will be based largely on the recommendations outlined in the expert group report, chaired by former Finnish Prime Minister Esko Aho, and prepared on behalf of the European Commission. "The basic point of departure is a broadening of perspectives to include the demand for innovation," states the Finnish government.

The way to improve the EU's innovation policy is to develop markets that encourage innovation and create new demand, states the Finnish priorities paper. Important factors listed include standards, public procurements, enhancing the efficient operation of the market, mobility of research resources, and closer cooperation between universities and businesses.

On research, Finland aims to conclude negotiations on FP7 so that the programme can be launched at the start of 2007. A formal Competitiveness Council will take place on 25 September.

Further information on the research and innovation activities of the Finnish Presidency will be available from 3 July at:
http://cordis.europa.eu/finland

For other information on the Finnish Presidency, please see:
http://www.eu2006.fi

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...